Quantitative assay for the detection of the V617F variant in the Janus kinase 2 (JAK2) gene using the Luminex xMAP technology (Q33548521)

28 July 2017

title

Quantitative assay for the detection of the V617F variant in the Janus kinase 2 (JAK2) gene using the Luminex xMAP technology (English)

1 reference

28 July 2017

François W Paradis

1

1 reference

28 July 2017

Raynald Simard

series ordinal

2

1 reference

28 July 2017

Daniel Gaudet

series ordinal

3

1 reference

28 July 2017

publication date

1 April 2010

1 reference

28 July 2017

1 reference

28 July 2017

volume

11

1 reference

28 July 2017

page(s)

54

1 reference

JAK2 V617F/C618R mutation in a patient with polycythemia vera: a case study and review of the literature.

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861026

Concordance of assays designed for the quantification of JAK2V617F: a multicenter study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861026

JAKs in pathology: role of Janus kinases in hematopoietic malignancies and immunodeficiencies.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861026

The saga of JAK2 mutations and translocations in hematologic disorders: pathogenesis, diagnostic and therapeutic prospects, and revised World Health Organization diagnostic criteria for myeloproliferative neoplasms

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861026

JAK and MPL mutations in myeloid malignancies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861026

Development of a quantitative real-time polymerase chain reaction assay for the detection of the JAK2 V617F mutation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861026

Evidence that the JAK2 G1849T (V617F) mutation occurs in a lymphomyeloid progenitor in polycythemia vera and idiopathic myelofibrosis.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861026

JAK2 V617F in myeloid disorders: molecular diagnostic techniques and their clinical utility: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861026

Applications of Luminex xMAP technology for rapid, high-throughput multiplexed nucleic acid detection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861026

A gain-of-function mutation of JAK2 in myeloproliferative disorders

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861026

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861026

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861026

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861026

After chronic myelogenous leukemia: tyrosine kinase inhibitors in other hematologic malignancies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861026

Receptor tyrosine kinases in normal and malignant haematopoiesis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861026

Janus kinases: components of multiple signaling pathways

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861026

The molecular biology of chronic myeloid leukemia.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861026

Rapid, efficient method for multiplex amplification from filter paper

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861026

Validity test study of JAK2 V617F and allele burden quantification in the diagnosis of myeloproliferative diseases.

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-11-54

A simple, rapid, and sensitive method for the detection of the JAK2 V617F mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-11-54

JAK2-V617F mutation analysis of granulocytes and platelets from patients with chronic myeloproliferative disorders: advantage of studying platelets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-11-54

B-, T-, and NK-cell lineage involvement in JAK2V617F-positive patients with idiopathic myelofibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-11-54

Automated JAK2V617F quantification using a magnetic filtration system and sequence-specific primer-single molecule fluorescence detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-11-54

Mutation profile of JAK2 transcripts in patients with chronic myeloproliferative neoplasias

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-11-54

Rapid screening for 31 mutations and polymorphisms in the cystic fibrosis transmembrane conductance regulator gene by Lminex xMAP suspension array.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861026

The JAK2V617F mutation is detectable at very low level in peripheral blood of healthy donors

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20359349

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The JAK2 V617F mutation involves B- and T-lymphocyte lineages in a subgroup of patients with Philadelphia-chromosome negative chronic myeloproliferative disorders

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20359349

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Comparison of whole blood vs purified blood granulocytes for the detection and quantitation of JAK2(V617F)

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20359349

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2350-11-54

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference

28 July 2017

1 reference